228
Views
3
CrossRef citations to date
0
Altmetric
Review

Drug utilization and medication costs at the end of life

, , , &
Pages 237-243 | Received 12 Jan 2016, Accepted 22 Feb 2016, Published online: 25 Mar 2016

References

  • Luiza VL, et al. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines. Cochrane Database Syst Rev. 2015;5:CD007017.
  • Daemmrich A, Mohanty A. Healthcare reform in the United States and China: pharmaceutical market implications. J Pharm Policy Pract. 2014;7(1):9.
  • World Health Organization. Introduction to drug utilization research. Oslo, Norway: WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services; 2003.
  • Wettermark B. The intriguing future of pharmacoepidemiology. Eur J Clin Pharmacol. 2013;69(Suppl 1):43–51.
  • Lamont EB. A demographic and prognostic approach to defining the end of life. J Palliat Med. 2005;8(Suppl 1):S12–21.
  • Masman AD, et al. Medication use during end-of-life care in a palliative care centre. Int J Clin Pharm. 2015;37(5):767–775.
  • National Clinical Guideline Centre. Care of the dying adult. (draft for consultation 29 July 2015). Manchester: NICE; 2015.
  • Fahlman C, et al. Prescription drug spending for Medicare+Choice beneficiaries in the last year of life. J Palliat Med. 2006;9(4):884–893.
  • Gaertner J, et al. Inpatient palliative care: a nationwide analysis. Health Policy. 2013;109(3):311–318 8.
  • Hinkka H, et al. Assessment of pain control in cancer patients during the last week of life: comparison of health centre wards and a hospice. Supportive Care in Cancer. 2001;9(6):428–434.
  • Hwang SJ, et al. Hospice offers more palliative care but costs less than usual care for terminal geriatric hepatocellular carcinoma patients: a nationwide study. J Palliat Med. 2013;16(7):780–785.
  • Moore PV, Bennett K, Normand C. The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand. Applied Health Economics and Health Policy. 2014;12(6):623–633.
  • Silveira MJ, Kazanis AS, Shevrin MP. Statins in the last six months of life: A recognizable, life-limiting condition does not decrease their use. J Palliat Med. 2008;11(5):685–693.
  • Tavčar P, et al. Drugs and their costs in the last six days of life: A retrospective study. Eur J Oncol Pharm. 2014;8(2):19–23.
  • WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2015.
  • El-Jawahri A, Greer JA, Temel JS. Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol. 2011;9(3):87–94.
  • Rabow M, et al. Moving upstream: a review of the evidence of the impact of outpatient palliative care. J Palliat Med. 2013;16(12):1540–1549.
  • Heppenstall CP, et al. Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care. Australas J Ageing. 2015. doi:10.1111/ajag.12220. [Epub ahead of print]
  • Ma G, Downar J. Noncomfort medication use in acute care inpatients comanaged by palliative care specialists near the end of life: a cohort study. Am J Hosp Palliat Care. 2014;31(8):812–819.
  • Vegda K, et al. Trends in health services utilization, medication use, and health conditions among older adults: a 2-year retrospective chart review in a primary care practice. BMC Health Serv Res. 2009;9:217.
  • Gysels M, et al. Diversity in defining end of life care: an obstacle or the way forward? PLoS One. 2013;8(7):e68002.
  • Hui D, et al. Concepts and definitions for “supportive care,” “best supportive care,” “palliative care,” and “hospice care” in the published literature, dictionaries, and textbooks. Support Care Cancer. 2013;21(3):659–685.
  • Hui D, et al. The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage. 2012;43(3):582–592.
  • Hui D, et al. Concepts and definitions for “actively dying,” “end of life,” “terminally ill,” “terminal care,” and “transition of care”: a systematic review. J Pain Symptom Manage. 2014;47(1):77–89.
  • Sade RM. Introduction. Defining the beginning and the end of human life: implications for ethics, policy. And Law. J Law Med Ethics. 2006;34(1):6–7.
  • Thompson G, McClement S. Defining and determining quality in end-of-life care. Int J Palliat Nurs. 2002;8(6):288–293.
  • American Academy of, H., et al. National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for quality palliative care, executive summary. J Palliat Med. 2004;7(5):611–627.
  • National Institute for Health and Clinical Excellence (NICE). Care of dying adults in the last days of life. Clinical Guideline 31. London: NICE; 2015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.